טוען...
High dose cyclophosphamide for GVHD prevention
PURPOSE OF REVIEW: Administration of high-dose cyclophosphamide (Cy) after transplantation inhibits both graft rejection and graft-versus-host-disease (GvHD) in mouse models of allogeneic blood or marrow transplantation (alloBMT). This strategy has recently been adapted to human transplantation. REC...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3138214/ https://ncbi.nlm.nih.gov/pubmed/20827187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0b013e32833eaf1b |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|